MyoKardia Inc (MYOK)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

1000 SIERRA POINT PARKWAY BRISBANE, CA 94005

MyoKardia, Inc. operates as a precision cardiovascular medicine company. The Company develops and commercializes targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. MyoKardia conducts its business in the United States.

Data based on most recent fiscal year report
Market Cap3.364 Billion Shares Outstanding46.23 Million Avg Volume553.172 Thousand
1-Yr BETA vs S&P TR1.068 Current Ratio8.71 Quick Ratio8.71
View SEC Filings from MYOK instead.

View recent insider trading info

Funds Holding MYOK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding MYOK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

5 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

POPOVITS KIMBERLY J

  • Director
0 2020-03-26 1

SANOFI

23,221,451 2020-03-09 0

GIANAKAKOS ANASTASIOS PRESIDENT AND CEO

  • Officer
  • Director
667,869 2020-03-02 16

FOX JONATHAN C SEE REMARKS

  • Officer
411,475 2020-03-02 0

PERRY MARK L

  • Director
64,231 2020-02-18 1

BAUER JAKE CHIEF BUSINESS OFFICER

  • Officer
0 2020-02-14 8

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
0 2020-02-14 3

LADD CYNTHIA J GENERAL COUNSEL

  • Officer
0 2020-02-14 3

HARRIS TAYLOR C. CHIEF FINANCIAL OFFICER

  • Officer
0 2020-02-14 3

FAIREY WILLIAM SEE REMARKS

  • Officer
0 2020-02-14 2

HOMCY CHARLES J CHAIRMAN OF PHARMACEUTICALS

  • Officer
  • Director
1,342,291 2020-02-10 0

CRANSTON MARY B

  • Director
18,428 2020-01-28 1

YARNO WENDY L

  • Director
0 2019-12-17 1

LEE JUNE EVP, CHIEF DEVELOPMENT OFFICER

  • Officer
4,153 2019-09-23 4

LEVIN MARK J

  • Director
  • 10% Owner
5,962,202 2019-07-22 0

MEEKER DAVID P

  • Director
0 2019-06-19 1

AGARWAL SUNIL

  • Director
0 2019-06-13 1

STARR KEVIN P

0 2019-06-05 0

TOPOL ERIC

  • Director
91,014 2019-05-31 0

LAMBING JOSEPH SEE REMARKS

  • Officer
0 2019-02-08 0

SEMIGRAN MARC CHIEF MEDICAL OFFICER

  • Officer
0 2019-02-08 0

CHAN STEVEN SEE REMARKS

  • Officer
0 2019-01-16 0

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

MCDOWELL ROBERT SCOTT CHIEF SCIENTIFIC OFFICER

  • Officer
1,158 2019-01-07 3

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
No longer subject to file 2018-03-07 0

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
1,102,356 2018-01-03 0

THIRD ROCK VENTURES II, L.P.

THIRD ROCK VENTURES GP II, L.P.

TRV GP II, LLC

THIRD ROCK VENTURES III, L.P.

THIRD ROCK VENTURES GP III, L.P.

TRV GP III, LLC

LEVIN MARK J

TEPPER ROBERT I

  • 10% Owner
1,496,598 2015-11-03 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-03-02 S 1,800 $65.19 d 81,818 667,869.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-03-02 S 2,070 $64.35 d 83,618 667,869.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-03-02 S 22 $65.97 d 81,796 667,869.00 direct yes

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-03-02 S 1,108 $63.40 d 85,688 667,869.00 direct yes

LADD CYNTHIA J - Officer GENERAL COUNSEL

2020-02-14 A 31,079 a 31,079 0.00 direct

BAUER JAKE - Officer CHIEF BUSINESS OFFICER

2020-02-14 A 14,591 a 14,591 0.00 direct

FAIREY WILLIAM - Officer SEE REMARKS

2020-02-14 A 39,022 a 39,022 0.00 direct

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-02-14 A 46,083 a 46,083 0.00 direct

MCDOWELL ROBERT SCOTT - Officer CHIEF SCIENTIFIC OFFICER

2020-02-14 A 38,818 a 38,818 0.00 direct

BAUER JAKE - Officer CHIEF BUSINESS OFFICER

2020-02-14 A 45,193 a 45,193 0.00 direct

HARRIS TAYLOR C. - Officer CHIEF FINANCIAL OFFICER

2020-02-14 A 14,871 a 14,871 0.00 direct

GIANAKAKOS ANASTASIOS - Director - Officer PRESIDENT AND CEO

2020-02-14 A 142,733 a 142,733 0.00 direct

LADD CYNTHIA J - Officer GENERAL COUNSEL

2020-02-14 A 10,034 a 10,034 0.00 direct

FAIREY WILLIAM - Officer SEE REMARKS

2020-02-14 A 12,598 a 12,598 0.00 direct

HARRIS TAYLOR C. - Officer CHIEF FINANCIAL OFFICER

2020-02-14 A 46,060 a 46,060 0.00 direct

MCDOWELL ROBERT SCOTT - Officer CHIEF SCIENTIFIC OFFICER

2020-02-14 A 12,533 a 12,533 0.00 direct

Elevate your investments